How to read: Every bubble is one Indian nitroglycerin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Nitroglycerin report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial nitroglycerin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian nitroglycerin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Nitroglycerin India trade report
P
Product scope
Nitroglycerin
All variants merged — branded and generic formulations of nitroglycerin
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
97
Every commercial nitroglycerin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a mixed: Oct $599.9K, Nov $151.2K, Dec $104.4K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$599.9K
Oct USD
17 shipments
2
$151.2K
Nov USD
-74.8% MoM
3
$104.4K
Dec USD
-30.9% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 74.8% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $600K, making it the strongest month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MANKIND PHARMA LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import nitroglycerin from India, how much they buy, and who supplies each market
KEY TAKEAWAYUnited States absorbs 86.9% of India’s 2025-Q4 nitroglycerin trade ($743.7K). Beyond the top 10 destinations, 28 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 11 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 28 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much nitroglycerin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$53K
6.2% of trade
11 countries · 44 shipments
Europe
$14K
1.6% of trade
1 countries · 1 shipments
Americas
$787K
92.0% of trade
8 countries · 34 shipments
Africa
$2K
0.2% of trade
8 countries · 17 shipments
Oceania
$18
0.0% of trade
1 countries · 1 shipments
Fig 4.1 United States is the #1 corridor ($744K) — 29 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian nitroglycerin it receives (light = low, dark = high). Orange arcs radiate from India to the top 29 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
United States
$744K
18
MANKIND PHARMA LTD
$383K
EUGIA PHARMA SPECIALITIES LTD
$207K
NATCO PHARMA LTD
$83K
2
Guyana
$37K
8
CIRON DRUGS AND PHARMACEUTICALS PVT LTD
$34K
H V A INTERNATIONAL
$3K
PEAK HEALTHCARE
$48
3
Sri Lanka
$18K
1
TROIKAA PHARMACEUTICALS LTD
$18K
—
—
—
—
4
Albania
$14K
1
SWISS PARENTERALS LTD
$14K
—
—
—
—
5
Myanmar
$10K
2
DREAM PHARMACEUTICAL
$10K
—
—
—
—
6
Afghanistan
$7K
4
SAMARTH LIFE SCIENCES PVT LTD
$3K
MANKIND PHARMA LTD
$2K
RESCUERS LIFE SCIENCES LTD
$969
7
Tajikistan
$6K
1
HEET HEALTHCARE PVT LTD
$6K
—
—
—
—
8
Guatemala
$6K
2
ASMOH LABORATORIES LTD
$6K
—
—
—
—
9
Oman
$4K
1
DEN MARK PHARMACEUTICALS PVT LTD
$4K
—
—
—
—
10
Nepal
$3K
2
MICRO LABS LTD
$3K
—
—
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 6.2% of USD — but United States is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
86.9%
#1 country share
United States alone
96.2%
Top 5 share
5 of 29 countries
99.8%
Top 15 share
Long tail of 14 countries = 0.2%
HHI 7585
Destination HHI
Highly concentrated
29
Countries served
Global pharma reach from India
11
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
43 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYMANKIND PHARMA LTD ($385.3K, 45.0% share) and EUGIA PHARMA SPECIALITIES LTD ($207.1K) together control 69.2% of India’s 2025-Q4 nitroglycerin trade. The top 5 suppliers hold 87.8%. 43 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian nitroglycerin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 MANKIND PHARMA LTD leads by $178K over EUGIA PHARMA SPECIALITIES LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: KOMAL EXPORTERS is #19 by value but #3 by volume.
Fig 5.2 MANKIND PHARMA LTD also leads by shipment count (10) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: KOMAL EXPORTERS moves from #3 by volume to #19 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 43 nitroglycerin suppliers split into strategic segments
KEY TAKEAWAY11 suppliers (25%) generate 97.4% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 MANKIND PHARMA LTD and EUGIA PHARMA SPECIALITIES LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 97.4% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
33 importers across 29 countries — who is buying Indian nitroglycerin and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 91.6% of total USD. 88% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian nitroglycerin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 LIFESTAR PHARMA LLC is the #1 importer at $343K (40.1%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian nitroglycerin prices vary by supplier, country and dosage form
KEY TAKEAWAYNitroglycerin prices span 1490879× ($0.0002 → $232.59). The coefficient of variation is 5.02. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. MANKIND PHARMA LTDSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. SAMARTH LIFE SCIENCESSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. TROIKAA PHARMACEUTICALS LTDSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. EUGIA PHARMA SPECIALITIESSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Nov 2025
BHARAT EXPLOSIVE…
Vietnam
Injection
8
$2K
$232.59
Sterile formulation premium
Dec 2025
SUNNY PHARMA
Montserrat
Injection
3
$101.70
$33.90
Sterile formulation premium
Dec 2025
SUNNY PHARMA
Anguilla
Injection
4
$121.47
$30.37
Sterile formulation premium
Oct 2025
EUGIA PHARMA SPE…
United States
Tablet
10K
$207K
$20.49
Specialty / small-batch
Dec 2025
MILTON LIFECARE …
Bahrain
Injection
50
$662.34
$13.25
Sterile formulation premium
Dec 2025
NIVIRA EXPORTS
Saint Vincent and the Grenadines
Injection
10
$45.24
$4.52
Sterile formulation premium
Oct 2025
SOINS IMPEX
Guyana
Tablet
4
$17.64
$4.41
Specialty / small-batch
Dec 2025
FALCON TRANSGLOBAL
United Arab Emirates
sublingual tablet
2
$8.76
$4.38
Specialty / small-batch
Dec 2025
MOVID IMPEX
United Arab Emirates
Tablet
3
$13.11
$4.37
Specialty / small-batch
Nov 2025
SAMARTH LIFE SCI…
Afghanistan
Injection
400
$2K
$4.14
Sterile formulation premium
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
BARAKAH BIOHEALT…
Tanzania
Injection
150
$0.475
$0.0032
Sterile formulation premium
Dec 2025
BARAKAH BIOHEALT…
Tanzania
Injection
550
$1.74
$0.0032
Sterile formulation premium
Dec 2025
ASMOH LABORATORI…
Guatemala
Injection
1K
$5.58
$0.0056
Sterile formulation premium
Oct 2025
NATCO PHARMA LTD
United States
Tablet
1.1M
$20K
$0.018
Bulk volume discount
Oct 2025
NATCO PHARMA LTD
United States
Tablet
314K
$6K
$0.018
Oct 2025
MANKIND PHARMA LTD
United States
sublingual
1.7M
$32K
$0.019
Bulk volume discount
Nov 2025
MANKIND PHARMA LTD
United States
Tablet
220K
$4K
$0.019
Nov 2025
MANKIND PHARMA LTD
United States
Tablet
2.0M
$40K
$0.020
Bulk volume discount
Nov 2025
MANKIND PHARMA LTD
United States
sublingual tablet
236K
$5K
$0.021
Oct 2025
NATCO PHARMA LTD
United States
Tablet
1.1M
$29K
$0.027
Bulk volume discount
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship nitroglycerin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYNitroglycerin leaves India through 14+ ports. The top 5 (MUNDRA SEA, HYDERABAD AIR, NHAVA SHEVA SEA (JNPT)) handle 97.0% of total USD. SEA moves 27% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUNDRA SEA handles $388K — top 14 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYSEA dominates at 27% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$506K
59.1% of USD · 26.8% of ships
AIR
$324K
37.8% of USD · 67.0% of ships
ICD
$23K
2.6% of USD · 4.1% of ships
ROAD
$3K
0.4% of USD · 2.1% of ships
Fig 8.3 The dominant corridor is MUNDRA SEA → Sea → N. America ($384K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYTanzania is the most concentrated destination (HHI 10000, 1 suppliers). United States is the most competitive (HHI 3598).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Tanzania (HHI 10,000) is the most concentrated — United States (HHI 3,598) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
LIFESTAR PHARMA LLC
United States
MANKIND PHARMA LTD
$343K
8
HIGH
EUGIA US LLC
United States
EUGIA PHARMA SPE…
$207K
1
HIGH
LIFE SCIENCE LOGISTICS
United States
NATCO PHARMA LTD
$83K
4
MEDIUM
NORTHSTAR DISTRIBUTI…
United States
MANKIND PHARMA LTD
$40K
1
MEDIUM
EVERSANA LIFE SCIENC…
United States
RUBICON RESEARCH…
$32K
2
MEDIUM
IPD, SC
United States
ENCUBE ETHICALS …
$29K
1
MEDIUM
S . P . C . O . L. .…
Sri Lanka
TROIKAA PHARMACE…
$18K
1
MEDIUM
EVERSANA LIFE SCIENC…
United States
RUBICON RESEARCH…
$9K
1
MEDIUM
Conclusion: 29 buyers depend on exactly one Indian supplier, representing $783K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
EMIRATES POST GROUP
United Arab Emirates
3
$25
MOVID IMPEX
MEDIUM
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
United States
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Guyana
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Sri Lanka
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Albania
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Myanmar
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Afghanistan
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Tajikistan
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Guatemala
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Oman
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Nepal
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Vietnam
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Turkey
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Maldives
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Mauritius
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Bahrain
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in United States
This Q
HIGH
A2
Offer alternative to EMIRATES POST
This Q
HIGH
A3
Audit Tanzania lock-ins (HHI 10000)
This Q
MED
A5
Enter United States (5 suppliers)
This Q
HIGH
A6
Enter Guyana (4 suppliers)
This Q
MED
A8
Build Guyana distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (climbers)
This Q
MED
A7
Register for United States tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
United States
Other
5
$744K
-87.3%
LOW
Low competition (5 suppliers), accessible market
2
Guyana
Other
4
$37K
-87.6%
LOW
Low competition (4 suppliers), accessible market
3
Sri Lanka
Asia
1
$18K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
4
Albania
Other
1
$14K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
5
Myanmar
Asia
1
$10K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
6
Afghanistan
Asia
3
$7K
0%
LOW
Low competition (3 suppliers), accessible market
7
Tajikistan
Asia
1
$6K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
8
Guatemala
Other
1
$6K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
9
Oman
Other
1
$4K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
10
Nepal
Asia
1
$3K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
11
Vietnam
Asia
1
$2K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Turkey
Other
1
$2K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
Maldives
Asia
3
$936
0%
LOW
Low competition (3 suppliers), accessible market
14
Mauritius
Africa
1
$861
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
15
Bahrain
Other
1
$662
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 97 2025-Q4 Nitroglycerin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/nitroglycerin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 97 2025-Q4 nitroglycerin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian nitroglycerin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
97
across all regions
TOTAL USD
$856K
2025-Q4 FOB value
UNITS
20.1M
tablets, capsules, etc.
SUPPLIERS
43
Indian exporters
BUYERS
33
global importers
COUNTRIES
29
destinations
§10.2 Regional breakdown
Africa
$2K
0.2%
8 ctry · 17 ships
Asia
$53K
6.2%
11 ctry · 44 ships
Europe
$14K
1.6%
1 ctry · 1 ships
Americas
$787K
92.0%
8 ctry · 34 ships
Oceania
$18.36
0.0%
1 ctry · 1 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $2K (0.2%), spanning 8 countries.
🏢
43 Indian suppliers shipped to 33 buyers across 29 countries — average shipment value $9K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 31 global nitroglycerin importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian nitroglycerin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
LIFESTAR PHARMA LLC
United States
8
$343K
MANKIND PHARMA LTD
sublingual_tablet, sublingual, sublingual tablet
2
EUGIA US LLC
United States
1
$207K
EUGIA PHARMA SPECIAL…
Tablet
3
LIFE SCIENCE LOGISTICS
United States
4
$83K
NATCO PHARMA LTD
Tablet
4
NORTHSTAR DISTRIBUTION CENTER
United States
1
$40K
MANKIND PHARMA LTD
Tablet
5
EVERSANA LIFE SCIENCE SERVICES LLC
United States
2
$32K
RUBICON RESEARCH LTD
sub-lingual tablet, sub tablet
6
IPD, SC
United States
1
$29K
ENCUBE ETHICALS PVT …
Ointment
7
S . P . C . O . L. . SRI LANKASRI L
Sri Lanka
1
$18K
TROIKAA PHARMACEUTIC…
Tablet
8
EVERSANA LIFE SCIENCES SERVICES LLC
United States
1
$9K
RUBICON RESEARCH LTD
Tablet
9
LLC ILHOM PHARMA
Tajikistan
1
$6K
HEET HEALTHCARE PVT …
Tablet
10
SAMMRIDHI PHARMACEUTICALS
Nepal
2
$3K
MICRO LABS LTD
Gel
11
NEW GPC INC
Guyana
1
$3K
H V A INTERNATIONAL
Injection
12
ZAHIR HADROGULL LTD
Afghanistan
1
$2K
MANKIND PHARMA LTD
Tablet
13
VINH PHUC PHARMACEUTICAL JOINT
Vietnam
1
$2K
BHARAT EXPLOSIVES LTD
Injection
14
TRUST ANESTHETIC LTD
Afghanistan
1
$2K
SAMARTH LIFE SCIENCE…
Injection
15
ETEMED MOSLEH LTD
Afghanistan
1
$969.34
RESCUERS LIFE SCIENC…
Injection
16
FTM (MAURITIUS) LTD
Mauritius
2
$860.54
MODI-MUNDIPHARMA PVT…
Tablet
17
GULF PHARMACIES W.L.L
Bahrain
1
$662.34
MILTON LIFECARE PVT …
Injection
18
ALLIANCE PHARMA SARL
Guinea-Bissau
2
$133.58
TRIDENT IMPEX
Injection
19
EMIRATES POST COMPANY
United Arab Emirates
17
$130.67
DERRIC WOOD
Tablet
20
PRINCESS ALEXANDRA HOSPITAL
Anguilla
1
$121.47
SUNNY PHARMA
Injection
21
CENTRAL MEDICAL STORES, MINISTRY OF
Montserrat
1
$101.70
SUNNY PHARMA
Injection
22
MEDIMART DRUG STORE
United Arab Emirates
1
$88.15
DROPS PHARMA PVT LTD
Injection
23
TO THE PURCHASE DEPARTMENT
Saint Vincent and the Grenadines
1
$45.24
NIVIRA EXPORTS
Injection
24
STATE TRADING ORGANIZATION PLC
Maldives
1
$39.36
MC PHARMA DISTRIBUTORS
controlled_release_tablets
25
EMIRATES POST GROUP
United Arab Emirates
3
$25.14
MOVID IMPEX
Tablet, sublingual tablet
26
KALKAAL HOSPITAL
Somalia
2
$19.67
CURE EARTH PHARMA
Injection, Tablet
27
MR SHALVIN KUMAR
Fiji
1
$18.36
RUN MEDWAY
Tablet
28
DR BALWANT SINGHS HOSPITAL INC
Guyana
1
$17.64
SOINS IMPEX
Tablet
29
ZMC EXPRESS CARGO FZCO
United Arab Emirates
2
$8.09
HUMANKIND PHARMA
Tablet
30
LUSAKA MEDICAMP LTD
Zambia
2
$6.15
MEDICOS LIFESCIENCES
Tablet
31
INVOICE RAISED TO
Grenada
1
$3.55
MEDIGEN PHARMA
Injection
This report covers 97 2025-Q4 Nitroglycerin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/nitroglycerin
Talk to our trade analyst
Need a custom nitroglycerin report or a deeper dive into any market? Our team is ready.